Reply to: Partially Levodopa-Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant.

Authors :: Nardecchia F
Martinelli S
Pollini L
Leuzzi V
Source :: Movement disorders clinical practice [Mov Disord Clin Pract] 2024 Jun; Vol. 11 (6), pp. 751-752. Date of Electronic Publication: 2024 Apr 14.
Publication Year :: 2024

Subjects :: Humans
Antiparkinson Agents therapeutic use
Antiparkinson Agents administration & dosage
Antiparkinson Agents pharmacology
Levodopa therapeutic use
Levodopa administration & dosage
Parkinsonian Disorders drug therapy
Parkinsonian Disorders genetics

Full Text Access

Tools